** Shares in Redcare Pharmacy RDC.DE rise 4.4% in early Frankfurt trade after the German online drug retailer posted preliminary Q2 revenue above last year's level and confirmed FY guidance for 2025
** Its Q2 revenue was 709 million euros ($836.7 million), up 26.4% from 561 million a year earlier, though it slightly missed analysts' expectations of 711.3 million euros according to LSEG data
** "No brilliant report. But should overall be good enough for a bounce of depressed shares," a local trader says
** The stock, which had lost 31.6% YTD as of Wednesday's close, is seen at the top of Germany's mid-cap .MDAXI index
($1 = 0.8474 euros)
(Reporting by Ozan Ergenay)
((ozan.ergenay@thomsonreuters.com))